abstract |
The present invention relates to CCR5 receptor antagonists of formulae (1 a ) or (1 b ): n nenantiomers, diastereomers, salts and solvates thereof wherein R 1 , R 2 , R 3 , R 4 , R 5 , and R 7 are as defined herein. The invention further includes a method of CCR5-mediated disorders employing such compounds. |